Drug Cos. Not Ready for 'Deep End' of Remote Trials
By Kaitlin Gebby · February 1, 2024, 7:47 PM EST
Enthusiasm among drug companies and federal officials about increasing diversity among clinical subjects through "decentralized" trials is being tempered by unknowns about the regulatory landscape, a group of experts said Thursday....
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login